1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Tapinarof Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Innovator
  • 1.3.3 Generic
• 1.4 Market Analysis by Specification
  • 1.4.1 Overview: Global Tapinarof Consumption Value by Specification: 2021 Versus 2025 Versus 2032
  • 1.4.2 10 g/tube
  • 1.4.3 20 g/tube
• 1.5 Market Analysis by Sales Channel
  • 1.5.1 Overview: Global Tapinarof Consumption Value by Sales Channel: 2021 Versus 2025 Versus 2032
  • 1.5.2 Hospital
  • 1.5.3 Retail
  • 1.5.4 Online
• 1.6 Market Analysis by Application
  • 1.6.1 Overview: Global Tapinarof Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.6.2 Mild to Moderate Plaque Psoriasis In Adults
  • 1.6.3 Atopic Dermatitis (AD) In Children And Adolescents
  • 1.6.4 Chronic Eczema, Neurodermatitis, Seborrheic dermatitis
  • 1.6.5 Others
• 1.7 Global Tapinarof Market Size & Forecast
  • 1.7.1 Global Tapinarof Consumption Value (2021 & 2025 & 2032)
  • 1.7.2 Global Tapinarof Sales Quantity (2021-2032)
  • 1.7.3 Global Tapinarof Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Guangdong Zhonghao Pharmaceutical
  • 2.1.1 Guangdong Zhonghao Pharmaceutical Details
  • 2.1.2 Guangdong Zhonghao Pharmaceutical Major Business
  • 2.1.3 Guangdong Zhonghao Pharmaceutical Tapinarof Product and Services
  • 2.1.4 Guangdong Zhonghao Pharmaceutical Tapinarof Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Guangdong Zhonghao Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Tapinarof by Manufacturer

• 3.1 Global Tapinarof Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global Tapinarof Revenue by Manufacturer (2021-2026)
• 3.3 Global Tapinarof Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of Tapinarof by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 Tapinarof Manufacturer Market Share in 2025
  • 3.4.3 Top 6 Tapinarof Manufacturer Market Share in 2025
• 3.5 Tapinarof Market: Overall Company Footprint Analysis
  • 3.5.1 Tapinarof Market: Region Footprint
  • 3.5.2 Tapinarof Market: Company Product Type Footprint
  • 3.5.3 Tapinarof Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Tapinarof Market Size by Region
  • 4.1.1 Global Tapinarof Sales Quantity by Region (2021-2032)
  • 4.1.2 Global Tapinarof Consumption Value by Region (2021-2032)
  • 4.1.3 Global Tapinarof Average Price by Region (2021-2032)
• 4.2 North America Tapinarof Consumption Value (2021-2032)
• 4.3 Europe Tapinarof Consumption Value (2021-2032)
• 4.4 Asia-Pacific Tapinarof Consumption Value (2021-2032)
• 4.5 South America Tapinarof Consumption Value (2021-2032)
• 4.6 Middle East & Africa Tapinarof Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global Tapinarof Sales Quantity by Type (2021-2032)
• 5.2 Global Tapinarof Consumption Value by Type (2021-2032)
• 5.3 Global Tapinarof Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global Tapinarof Sales Quantity by Application (2021-2032)
• 6.2 Global Tapinarof Consumption Value by Application (2021-2032)
• 6.3 Global Tapinarof Average Price by Application (2021-2032)

7 North America

• 7.1 North America Tapinarof Sales Quantity by Type (2021-2032)
• 7.2 North America Tapinarof Sales Quantity by Application (2021-2032)
• 7.3 North America Tapinarof Market Size by Country
  • 7.3.1 North America Tapinarof Sales Quantity by Country (2021-2032)
  • 7.3.2 North America Tapinarof Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe Tapinarof Sales Quantity by Type (2021-2032)
• 8.2 Europe Tapinarof Sales Quantity by Application (2021-2032)
• 8.3 Europe Tapinarof Market Size by Country
  • 8.3.1 Europe Tapinarof Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe Tapinarof Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific Tapinarof Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific Tapinarof Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific Tapinarof Market Size by Region
  • 9.3.1 Asia-Pacific Tapinarof Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific Tapinarof Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America Tapinarof Sales Quantity by Type (2021-2032)
• 10.2 South America Tapinarof Sales Quantity by Application (2021-2032)
• 10.3 South America Tapinarof Market Size by Country
  • 10.3.1 South America Tapinarof Sales Quantity by Country (2021-2032)
  • 10.3.2 South America Tapinarof Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa Tapinarof Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa Tapinarof Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa Tapinarof Market Size by Country
  • 11.3.1 Middle East & Africa Tapinarof Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa Tapinarof Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 Tapinarof Market Drivers
• 12.2 Tapinarof Market Restraints
• 12.3 Tapinarof Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Tapinarof and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Tapinarof
• 13.3 Tapinarof Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Tapinarof Typical Distributors
• 14.3 Tapinarof Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Tapinarof market size was valued at US$ 132 million in 2025 and is forecast to a readjusted size of US$ 611 million by 2032 with a CAGR of 24.4% during review period.
In 2025, global Tapinarof production reached approximately 650,000 units. Benvitimod is a novel non-steroidal topical small-molecule drug primarily used for the treatment of inflammatory skin diseases, with significant clinical value in conditions such as atopic dermatitis (eczema) and other chronic dermatological disorders. Its mechanism of action mainly involves regulating the skin’s immune response, inhibiting the release of inflammatory mediators, and improving the skin barrier function, thereby alleviating symptoms such as itching, erythema, and lesions.Compared with traditional corticosteroid drugs, benvitimod is associated with fewer adverse effects and offers higher safety for long-term use. It is suitable for patients requiring maintenance therapy and has been increasingly adopted in dermatological clinical practice.
Benvitimod is a novel topical small-molecule aryl hydrocarbon receptor (AhR) modulator, primarily used for the treatment of inflammatory skin diseases such as psoriasis, and demonstrates strong innovation in the dermatology topical drug market. With the growing number of psoriasis patients and increasing demand for long-term safety and treatment adherence, the need for non-steroidal topical therapies continues to rise, providing favorable market growth opportunities for benvitimod.From a competitive landscape perspective, traditional topical treatments are still dominated by corticosteroids and vitamin D3 analogs, with products such as Calcipotriol holding a certain market share. Meanwhile, innovative drugs represented by Tapinarof have gradually entered the market in recent years, intensifying competition.Compared with conventional therapies, benvitimod offers a favorable balance of efficacy and safety without the use of steroids, making it particularly suitable for patients requiring long-term maintenance therapy and giving it differentiated competitive potential. At the same time, its gradual inclusion in medical insurance and ongoing market education efforts are expected to enhance physician awareness and patient accessibility. From a policy perspective, volume-based procurement and cost-control measures exert some pressure on pricing, while also promoting market expansion. Overall, the future market performance of benvitimod will depend on the accumulation of real-world efficacy data, expansion into new indications (such as atopic dermatitis), and its overall competitive balance in terms of safety, adherence, and pricing.
This report is a detailed and comprehensive analysis for global Tapinarof market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Tapinarof market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Tapinarof market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Tapinarof market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Tapinarof market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tapinarof
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tapinarof market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Guangdong Zhonghao Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Tapinarof market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Innovator
Generic
Market segment by Specification
10 g/tube
20 g/tube
Market segment by Sales Channel
Hospital
Retail
Online
Market segment by Application
Mild to Moderate Plaque Psoriasis In Adults
Atopic Dermatitis (AD) In Children And Adolescents
Chronic Eczema, Neurodermatitis, Seborrheic dermatitis
Others
Major players covered
Guangdong Zhonghao Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tapinarof product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tapinarof, with price, sales quantity, revenue, and global market share of Tapinarof from 2021 to 2026.
Chapter 3, the Tapinarof competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tapinarof breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Tapinarof market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tapinarof.
Chapter 14 and 15, to describe Tapinarof sales channel, distributors, customers, research findings and conclusion.